PeptiDream Inc. (PPTDF)
OTCMKTS · Delayed Price · Currency is USD
10.42
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
PeptiDream Revenue
PeptiDream had revenue of 4.31B JPY in the quarter ending September 30, 2025, a decrease of -21.15%. This brings the company's revenue in the last twelve months to 17.93B, down -62.47% year-over-year. In the year 2024, PeptiDream had annual revenue of 46.68B with 62.57% growth.
Revenue (ttm)
17.93B JPY
Revenue Growth
-62.47%
P/S Ratio
10.71
Revenue / Employee
23.72M JPY
Employees
756
Market Cap
1.30B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Vaxart | 148.20M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
| Northwest Biotherapeutics | 937.00K |
| Arch Biopartners | 198.11K |
PeptiDream News
- 8 days ago - Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan - GlobeNewsWire
- 2 months ago - PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis - Business Wire
- 2 months ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline Transcript - Seeking Alpha
- 2 months ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline - Slideshow - Seeking Alpha
- 1 year ago - PeptiDream: Opulent Dream Now A Reality - Seeking Alpha